July 2024
1. VAN KLEEF LA, Francque SM, Prieto-Ortiz JE, Sonneveld MJ, et al
   Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
   Gastroenterology. 2024;167:357-367.
   

   >> Share

   
   
2. NAIMIMOHASSES S, Bhat M
   Novel Multimodal Database for Metabolic Dysfunction-Associated Steatotic Liver Disease-Linking Genes to Outcomes.
   Gastroenterology. 2024;167:410-411.
   

   >> Share

   
   
3. SUI B, Wang R, Chen C, Kou X, et al
   Apoptotic Vesicular Metabolism Contributes to Organelle Assembly and Safeguards Liver Homeostasis and Regeneration.
   Gastroenterology. 2024;167:343-356.
   

   >> Share

   
   June 2024
4. ZENG T, Xiong J, Li X
   A rare cause of hepatic mass with high metabolic activity and jaundice.
   Gastroenterology. 2024 Jun 29:S0016-5085(24)05173.
   

   >> Share

   
   
5. SUTTON H, Bhat M
   Novel migratory hepatocyte population contributes to liver regeneration in acute liver injury.
   Gastroenterology. 2024 Jun 27:S0016-5085(24)05176.
   

   >> Share

   
   
6. KO S, Monga SP
   The dark side of human hepatocyte plasticity.
   Gastroenterology. 2024 Jun 25:S0016-5085(24)05116.
   

   >> Share

   
   
7. LENS S
   Resmetirom for Non-alcoholic Steatohepatitis.
   Gastroenterology. 2024 Jun 25:S0016-5085(24)05120.
   

   >> Share

   
   
8. VENKATESWARAN N
   Seladelpar as an alternate second line agent for Primary Biliary Cirrhosis.
   Gastroenterology. 2024 Jun 20:S0016-5085(24)05064.
   

   >> Share

   
   
9. ZHU CP, Liu SQ, Wang KQ, Xiong HL, et al
   Targeting 5-Hydroxytryptamine receptor 1A in portal vein to decrease portal hypertension.
   Gastroenterology. 2024 Jun 19:S0016-5085(24)05062.
   

   >> Share

   
   
10. HSU BY, Driscoll J, Tateno C, Mattis AN, et al
    Human Hepatocytes Can Give Rise To Intrahepatic Cholangiocarcinomas.
    Gastroenterology. 2024 Jun 10:S0016-5085(24)05028.
    

    >> Share

    
    
11. LEE BP, Louvet A
    Longitudinal Change of Alcohol Use is a Dynamic Contributor to Steatotic Liver Disease Progression.
    Gastroenterology. 2024;166:965-967.
    

    >> Share

    
    
12. LO GH
    The Optimal Duration of Vasoconstrictors for Acute Variceal Hemorrhage: Longer Is Safer?
    Gastroenterology. 2024;166:1197-1198.
    

    >> Share

    
    
13. WANG H, Yuan S, Zheng Q, Zhang S, et al
    Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
    Gastroenterology. 2024;166:1130-1144.
    

    >> Share

    
    May 2024
14. HANSCOM M
    Magnetically guided capsule endoscopy comparable to EGD for detecting esophagogastric varices in patients with cirrhosis.
    Gastroenterology. 2024 May 28:S0016-5085(24)05001.
    

    >> Share

    
    
15. HILSCHER MB, Wysokinski WE, Andrews JC, Simonetto DA, et al
    Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management Strategies.
    Gastroenterology. 2024 May 25:S0016-5085(24)04951.
    

    >> Share

    
    
16. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.
    

    >> Share

    
    
17. NIEMI NM, Debosch BJ
    Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
    Gastroenterology. 2024;166:936-937.
    

    >> Share

    
    
18. GEORGE B, Kudryashova O, Kravets A, Thalji S, et al
    Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
    Gastroenterology. 2024;166:859-871.
    

    >> Share

    
    
19. SCHONAUER R, Sierks D, Boerrigter M, Jawaid T, et al
    Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
    Gastroenterology. 2024;166:902-914.
    

    >> Share

    
    April 2024
20. WANG L, Berger NA, Kaelber DC, Xu R, et al
    Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes.
    Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
    

    >> Share

    
    
21. JIANG C, Lian M, Ma X
    A Rare Case Mimicking Congenital Hepatic Fibrosis.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00483.
    

    >> Share

    
    March 2024
22. CAMPANI C, Guido M, Marra F
    Elusive hepatic nodules.
    Gastroenterology. 2024 Mar 23:S0016-5085(24)00355.
    

    >> Share

    
    
23. HOLTZ LR, DeBosch BJ
    Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
    Gastroenterology. 2024;166:534-535.
    

    >> Share

    
    
24. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
    PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
    Gastroenterology. 2024;166:515-517.
    

    >> Share

    
    
25. GAO F, Seto WK, Zheng MH
    Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
    Gastroenterology. 2024;166:541-542.
    

    >> Share

    
    
26. AN T, Liu L, Li X
    Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
    Gastroenterology. 2024;166:540-541.
    

    >> Share

    
    February 2024
27. WONG RJ, Yang Z, Cheung R, Singal AK, et al
    Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
    Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
    

    >> Share

    
    
28. CHEN J, Feng W, Sun M, Huang W, et al
    TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
    Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
    

    >> Share

    
    
29. ALLEN AM, Pose E, Reddy KR, Russo MW, et al
    Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges.
    Gastroenterology. 2024;166:229-234.
    

    >> Share

    
    
30. WALAYAT S, Pfau P
    2 AM in the Intensive Care Unit: What Could Go Wrong?
    Gastroenterology. 2024;166:e13-e15.
    

    >> Share

    
    
31. BILAL M, Steinberg J, Louissaint J, Phan J, et al
    First Year on the Job as a Gastroenterologist and Hepatologist: Lessons Learned.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00125.
    

    >> Share

    
    January 2024
32. POSE E, Piano S, Juanola A, Gines P, et al
    HEPATORENAL SYNDROME IN CIRRHOSIS.
    Gastroenterology. 2024 Jan 19:S0016-5085(24)00054.
    

    >> Share

    
    
33. LAURIDSEN MM, Gronkjaer LL, Khraibut S, Patel N, et al
    The multi-dimensional challenge of poor oral health in cirrhosis - disparities and solutions.
    Gastroenterology. 2024 Jan 13:S0016-5085(24)00043.
    

    >> Share

    
    
34. MULLISH BH
    Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?
    Gastroenterology. 2024;166:213-214.
    

    >> Share

    
    
35. ZENG Q, Wu D, Tang H
    A Mysterious Abdominal Pain.
    Gastroenterology. 2024;166:27-30.
    

    >> Share

    
    December 2023
36. MEZZACAPPA C, Bhat M
    Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests?
    Gastroenterology. 2023;165:1576.
    

    >> Share

    
    November 2023
37. GARCIA-TSAO G, Abraldes JG, Rich NE, Wong VW, et al
    AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Gastroenterology. 2023 Nov 17:S0016-5085(23)05143.
    

    >> Share

    
    
38. KOJIMA H, Kadono K, Hirao H, Dery KJ, et al
    T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans.
    Gastroenterology. 2023;165:1233-1248.
    

    >> Share

    
    
39. PENA-SANCHEZ JN, Osei JA, Teucher U, Tremblay M, et al
    Working With Indigenous Community and Patient Partners Is Essential to Advance Gastroenterology and Hepatology Research: Perspectives From Canada.
    Gastroenterology. 2023;165:1097-1101.
    

    >> Share

    
    
40. LLOVET JM, Heikenwalder M
    Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology.
    Gastroenterology. 2023;165:1308-1310.
    

    >> Share

    
    October 2023
41. AMPUERO J, Berzigotti A
    Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
    Gastroenterology. 2023;165:829-831.
    

    >> Share

    
    
42. SEMMLER G, Yang Z, Fritz L, Kock F, et al
    Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
    Gastroenterology. 2023;165:1041-1052.
    

    >> Share

    
    
43. MAN S, Deng Y, Ma Y, Fu J, et al
    Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
    Gastroenterology. 2023;165:1025-1040.
    

    >> Share

    
    
44. YIP TC, Fan JG, Wong VW
    China's Fatty Liver Crisis: A Looming Public Health Emergency.
    Gastroenterology. 2023;165:825-827.
    

    >> Share

    
    
45. TICA S, Debosch BJ
    Bariatric Surgery for the Treatment of NASH-An Old Solution to a Newer Problem?
    Gastroenterology. 2023;165:1091.
    

    >> Share

    
    
46. WATTACHERIL JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al
    AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2023;165:1080-1088.
    

    >> Share

    
    September 2023
47. CHEN J, Yang Q, Wang C
    Multiple Hepatic Masses in a Patient with Crohn's disease.
    Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
    

    >> Share

    
    
48. XIE L, Guo H
    Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the incidence and risk factors of hepatic steatosis and hepatic fibrosis in the Chinese population.
    Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.
    

    >> Share

    
    
49. MEZZACAPPA C
    Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination.
    Gastroenterology. 2023 Sep 6:S0016-5085(23)04976.
    

    >> Share

    
    
50. NEWMAN KL, Velez C, Paul S, Radix AE, et al
    Research Considerations in Digestive and Liver Disease in Transgender and Gender-Diverse Populations.
    Gastroenterology. 2023;165:523-528.
    

    >> Share

    
    
51. WANG Y, Huang Y, Chase RC, Li T, et al
    Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019.
    Gastroenterology. 2023;165:773-783.
    

    >> Share

    
    
52. INTAGLIATA NM, Rahimi RS, Higuera-de-la-Tijera F, Simonetto DA, et al
    Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study.
    Gastroenterology. 2023;165:717-732.
    

    >> Share

    
    
53. ZUO T, Xie Q, Liu J, Yang J, et al
    Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis.
    Gastroenterology. 2023;165:746-761.
    

    >> Share

    
    
54. FLIGOR SC, Tsikis ST, Hirsch TI, Pan A, et al
    A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.
    Gastroenterology. 2023;165:733-745.
    

    >> Share

    
    
55. WASSERMAN R, Reddy S, Grider D
    An Unusual Manifestation of Elevated Liver Enzymes and Architecture.
    Gastroenterology. 2023;165:e4-e6.
    

    >> Share

    
    August 2023
56. HUANG DQ, Wilson LA, Behling C, Kleiner DE, et al
    Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
    Gastroenterology. 2023;165:463-472.
    

    >> Share

    
    
57. NAIMIMOHASSES S, Bhat M
    Genomic Analysis of Hair From Celebrated Composer Provides Insight Into Liver Disease Susceptibility.
    Gastroenterology. 2023;165:514.
    

    >> Share

    
    
58. DEBOSCH BJ
    Next-Generation Farnesoid X Receptor Agonists in NASH Treatment: Are We There Yet?
    Gastroenterology. 2023;165:513-514.
    

    >> Share

    
    
59. PENG Z, Li S, Pi R
    A Giant Cystic Liver Mass in an Elderly Man.
    Gastroenterology. 2023;165:e5-e7.
    

    >> Share

    
    
60. ZHANG XF, Yin ZK, Zhang JY
    An Unusual Case of Intermittent Fever With Multiple Liver Lesions.
    Gastroenterology. 2023;165:e11-e14.
    

    >> Share

    
    
61. KHAN AA, Turki M, Frandah W
    An Unusual Case of Hematemesis.
    Gastroenterology. 2023;165:e8-e10.
    

    >> Share

    
    
62. SHEN C, Zhang J, Xia Q
    Unexpected Abdominal Wall Varices After Split-Liver Transplantation.
    Gastroenterology. 2023;165:354-356.
    

    >> Share

    
    July 2023
63. REDDY KR, McLerran D, Marsh T, Parikh N, et al
    Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
    Gastroenterology. 2023 Jul 8:S0016-5085(23)04765.
    

    >> Share

    
    
64. LO YN, Wu JS, Chiang HC
    A Pseudo-Gastric Bubble.
    Gastroenterology. 2023;165:e16-e18.
    

    >> Share

    
    
65. LI GF, Yu G
    Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System.
    Gastroenterology. 2023;165:305-306.
    

    >> Share

    
    
66. DEBOSCH B
    Obeying the Law: Energy Balance in Alternate-Day Fasting, Exercise, or Both Together in Patients With Obesity and NAFLD.
    Gastroenterology. 2023;165:301.
    

    >> Share

    
    
67. RATZIU V, Friedman SL
    Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
    Gastroenterology. 2023;165:5-10.
    

    >> Share

    
    June 2023
68. NISHIWAKI T, Tsutsumi Y, Nakaji S
    A mysterious hepatic mass.
    Gastroenterology. 2023 Jun 15:S0016-5085(23)00879.
    

    >> Share

    
    
69. CHINNASAMY V, Sakulsaengprapha V, Mathews SC
    The Benefit of Artificial Intelligence-Based Diagnosis in Gastroenterology and Hepatology is Highly Variable: A Diagnostic Need and Burden Analysis.
    Gastroenterology. 2023 Jun 2:S0016-5085(23)00818.
    

    >> Share

    
    
70. THIELE M, Suvitaival T, Trost K, Kim M, et al
    Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis.
    Gastroenterology. 2023;164:1248-1260.
    

    >> Share

    
    
71. SCHEINER B, Pinato DJ
    Tumor-infiltrating Neutrophils: Gatekeepers in Liver Cancer Immune Control.
    Gastroenterology. 2023;164:1338-1339.
    

    >> Share

    
    
72. MULLISH BH
    The Impact of Proportional Dietary Carbohydrate and Fat Content on Type 2 Diabetes and NAFLD.
    Gastroenterology. 2023;164:1338.
    

    >> Share

    
    
73. LIU W, Wei DH, Tong QY
    The Bull's-Eye Sign in Liver: Are They Liver Metastases?
    Gastroenterology. 2023;164:1056-1058.
    

    >> Share

    
    May 2023
74. FARIAS AQ, Vilalta AC, Zitelli PM, Pereira G, et al
    Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America.
    Gastroenterology. 2023 May 30:S0016-5085(23)00806.
    

    >> Share

    
    
75. YANG XM, Wang XQ, Hu LP, Feng MX, et al
    Nucleolar HEATR1 upregulated by mTORC1 signaling promotes hepatocellular carcinoma growth by dominating ribosome biogenesis and proteome homeostasis.
    Gastroenterology. 2023 May 27:S0016-5085(23)00802.
    

    >> Share

    
    
76. WANG J, Yu H, Dong W, Zhang C, et al
    N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/beta-Catenin and Hippo Signaling Pathways.
    Gastroenterology. 2023;164:990-1005.
    

    >> Share

    
    April 2023
77. CHO MY, Sung PS, Lee SH
    Multiple Hepatic Artery Pseudoaneurysms with Eosinophilia.
    Gastroenterology. 2023 Apr 26:S0016-5085(23)00629.
    

    >> Share

    
    
78. HAN H, Ge X, Babu Komakula SS, Desert R, et al
    MACROPHAGE-DERIVED OSTEOPONTIN (SPP1) PROTECTS FROM NON-ALCOHOLIC STEATOHEPATITIS.
    Gastroenterology. 2023 Apr 5:S0016-5085(23)00581.
    

    >> Share

    
    
79. GOLDOWSKY A, Ding J, Velez C, Paul S, et al
    Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology.
    Gastroenterology. 2023;164:510-514.
    

    >> Share

    
    
80. XU X, Alanaeme J, Wen Y, Colantonio LD, et al
    Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population.
    Gastroenterology. 2023;164:688-689.
    

    >> Share

    
    
81. GADIYARAM S, Nachiappan M
    An Unusual Cause of Lower Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:e4-e7.
    

    >> Share

    
    March 2023
82. EINER C, Munk DE, Park E, Akdogan B, et al
    ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson Disease rats.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00529.
    

    >> Share

    
    
83. GADIYARAM S, Nachiappan M, Kini D
    Liver SOL in a case of colon cancer, a red herring.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00534.
    

    >> Share

    
    
84. KO PH, Tseng CW
    An Unusual Cause of Acute Cholecystitis.
    Gastroenterology. 2023 Mar 23:S0016-5085(23)00531.
    

    >> Share

    
    
85. KUCUKKOSE E, Laoukili J, Gorelick AN, Degner S, et al
    Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer.
    Gastroenterology. 2023 Mar 9:S0016-5085(23)00256.
    

    >> Share

    
    
86. SAITO Y, Yin D, Kubota N, Wang X, et al
    A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00235.
    

    >> Share

    
    
87. ESPINOZA M, Muiquith M, Lim M, Zhu H, et al
    Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00234.
    

    >> Share

    
    
88. YANG S, Qian L, Li Z, Li Y, et al
    Integrated Multi-Omics Landscape of Liver Metastases.
    Gastroenterology. 2023;164:407-423.
    

    >> Share

    
    
89. NICOLETTI P, Dellinger A, Li YJ, Barnhart HX, et al
    Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
    Gastroenterology. 2023;164:454-466.
    

    >> Share

    
    
90. SUN J, Debosch B
    Guardian, Intermediary, or Perpetrator? New Insights Into Environmental Exposure, the Gut Microbiome, and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2023;164:492.
    

    >> Share

    
    
91. SHA M, Tong Y, Cao J
    "Malignant" Liver Lesions in an Incidental But High-Risk Patient.
    Gastroenterology. 2023;164:e17-e19.
    

    >> Share

    
    
92. LIU R, Dai Z, Zhu C
    A Rare Cause of Liver Fibrosis in an Adolescent Woman.
    Gastroenterology. 2023;164:340-343.
    

    >> Share

    
    
93. NADOLSKY KZ
    Use of the Term "Lean" for Nonalcoholic Fatty Liver Disease in Individuals With Low Body Mass Index.
    Gastroenterology. 2023;164:502-503.
    

    >> Share

    
    
94. TAMBAKIS G, Florescu C, Tsoi E
    Three Lumens Full of Blood-An Unusual Case of Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:334-335.
    

    >> Share

    
    February 2023
95. L'HERMITE S, Bordet M, Rayer C
    A Woman With Recurrent Upper Gastrointestinal Bleeding.
    Gastroenterology. 2023 Feb 18:S0016-5085(23)00152.
    

    >> Share

    
    
96. ZHOU C, Weng J, Liu C, Liu S, et al
    Disruption of SLFN11 deficiency-induced CCL2 signaling and macrophage M2 polarization potentiates anti-PD-1 therapy efficacy in hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 14:S0016-5085(23)00137.
    

    >> Share

    
    
97. CHEN VL, Oliveri A, Miller MJ, Wijarnpreecha K, et al
    PNPLA3 genotype and diabetes identify patients with non-alcoholic fatty liver disease at high risk of incident cirrhosis.
    Gastroenterology. 2023 Feb 7:S0016-5085(23)00113.
    

    >> Share

    
    
98. TOH MR, Wong Yi Ting E, Wong Hei S, Ng Wei Tian A, et al
    Global epidemiology and genetics of hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 2:S0016-5085(23)00105.
    

    >> Share

    
    
99. UFERE NN, El-Jawahri A, Ritchie C, Lai JC, et al
    Promoting Prognostic Understanding and Health Equity for Patients With Advanced Liver Disease: Using "Best Case/Worst Case".
    Gastroenterology. 2023;164:171-176.
    

    >> Share

    
    
100. PATEL AA, Arnold RM, Taddei TH, Woodrell CD, et al
     "Am I Going to Die?": Delivering Serious News to Patients With Liver Disease.
     Gastroenterology. 2023;164:177-181.
     

     >> Share

     
     
101. DEBOSCH BJ
     A deCIDEdly New Germline Mutation That Protects Against Liver Disease.
     Gastroenterology. 2023;164:304-305.
     

     >> Share

     
     
102. ZHU Y, Li X, He S
     Identification and Treatment of an Unusual Cause of Gastrointestinal Bleeding.
     Gastroenterology. 2023;164:e17-e20.
     

     >> Share

     
     January 2023
103. XIAO X, Yao D, Yang J
     An uncommon upper gastrointestinal bleeding.
     Gastroenterology. 2023 Jan 27:S0016-5085(23)00052.
     

     >> Share

     
     
104. LIM M, Franses JW, Imperial R, Majeed U, et al
     EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma.
     Gastroenterology. 2023 Jan 25:S0016-5085(23)00056.
     

     >> Share

     
     
105. WANG B, Bonkovsky HL, Lim JK, Balwani M, et al
     AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
     Gastroenterology. 2023 Jan 13:S0016-5085(22)01356.
     

     >> Share

     
     
106. WONG GL, Hui VW, Yip TC, Lui GC, et al
     Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir.
     Gastroenterology. 2023;164:151-153.
     

     >> Share

     
     
107. MITZLAFF K, Sayk F, Solbach P
     Jaundice and Weight Gain After Autologous Stem Cell Transplantation in a 28-Year-Old Patient With Diffuse Large B-Cell Lymphoma.
     Gastroenterology. 2023;164:32-33.
     

     >> Share

     
     
108. SALIM Z, Laycock A, Hewavitharana C
     Abdominal Pain After Transarterial Chemoembolization.
     Gastroenterology. 2023;164:27-29.
     

     >> Share

     
     December 2022
109. MO TT, Li M, Wang XY
     An Unusual Cause of Portal Hypertension.
     Gastroenterology. 2022 Dec 30:S0016-5085(22)01453.
     

     >> Share

     
     
110. BLOCK PD, Farrell JJ, Li DK
     A Rare Cause of Gastrointestinal Bleeding after Pancreaticoduodenectomy.
     Gastroenterology. 2022 Dec 30:S0016-5085(22)01449.
     

     >> Share

     
     
111. YEOH BS, Saha P, Golonka RM, Zou J, et al
     Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer.
     Gastroenterology. 2022;163:1658-1671.
     

     >> Share

     
     
112. ZHU Y, Shi H, He S
     An Unusual Cause of Gastric Variceal Bleeding.
     Gastroenterology. 2022;163:1502-1504.
     

     >> Share

     
     
113. ROBBINS J, El Hassan I, Siebenburgen C
     Evaluation and Treatment of GI Bleeding in a 51-Year-Old Man.
     Gastroenterology. 2022;163:1498-1501.
     

     >> Share

     
     November 2022
114. OH AR, Jeong Y, Yu J, Minh Tam DT, et al
     Hepatocyte Kctd17 inhibition ameliorates glucose intolerance and hepatic steatosis caused by obesity-induced Chrebp stabilization.
     Gastroenterology. 2022 Nov 16:S0016-5085(22)01295.
     

     >> Share

     
     
115. ZHANG H, Peng Y, Tang X
     Comments on "Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand".
     Gastroenterology. 2022 Nov 14. pii: S0016-5085(22)01271.
     

     >> Share

     
     
116. WANG Z, Tai Y, Wu H
     A rare cause of abdominal pain after transjugular intrahepatic portosystemic shunt.
     Gastroenterology. 2022 Nov 10. pii: S0016-5085(22)01258.
     

     >> Share

     
     
117. BRANDI G, Tovoli F, Tavolari S
     Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?
     Gastroenterology. 2022 Nov 4. pii: S0016-5085(22)01252.
     

     >> Share

     
     
118. PRASOPPOKAKORN T, Rerknimitr R
     An Unusual Complication of Endoscopic Cyanoacrylate Injection for Gastric Varix.
     Gastroenterology. 2022;163:1186-1187.
     

     >> Share

     
     
119. MAGAHIS P, Rosenblatt R, Mahadev S
     An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.
     Gastroenterology. 2022;163:e3-e5.
     

     >> Share

     
     October 2022
120. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
     Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
     Gastroenterology. 2022 Oct 7. pii: S0016-5085(22)00721.
     

     >> Share

     
     
121. BEHARI J
     Needle-free Nonalcoholic Fatty Liver Disease Prognostication: Moving One Step Closer.
     Gastroenterology. 2022;163:819-822.
     

     >> Share

     
     
122. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
     Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
     Gastroenterology. 2022;163:1079-1089.
     

     >> Share

     
     
123. SHINGINA A, Sarkar M, Feld L
     On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
     Gastroenterology. 2022;163:792-794.
     

     >> Share

     
     
124. BAJAJ JS, Nagy LE
     Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
     Gastroenterology. 2022;163:840-851.
     

     >> Share

     
     September 2022
125. LI H, Zheng J, Xu Q, Yang Y, et al
     Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.
     Gastroenterology. 2022 Sep 28. pii: S0016-5085(22)01085.
     

     >> Share

     
     
126. DARA L
     No Necroptosis in Hepatocytes: The Final Nail in the Coffin?
     Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01083.
     

     >> Share

     
     
127. MURILLO PEREZ CF, Fisher H, Hiu S, Kareithi D, et al
     Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
     Gastroenterology. 2022 Sep 13. pii: S0016-5085(22)01060.
     

     >> Share

     
     
128. HABER PK, Castet F, Torres-Martin M, Andreu-Oller C, et al
     Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
     Gastroenterology. 2022 Sep 12. pii: S0016-5085(22)01039.
     

     >> Share

     
     
129. LONG MT, Noureddin M, Lim JK
     AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
     Gastroenterology. 2022;163:764-774.
     

     >> Share

     
     
130. LEE BP, Terrault NA
     Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.
     Gastroenterology. 2022;163:539-542.
     

     >> Share

     
     August 2022
131. PRESTON SP, Stutz MD, Allison CC, Nachbur U, et al
     Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies.
     Gastroenterology. 2022 Aug 26. pii: S0016-5085(22)01021.
     

     >> Share

     
     
132. LIU J, Feng G
     A 41-year-old man with an abdominal mass and hepatomegaly.
     Gastroenterology. 2022 Aug 17. pii: S0016-5085(22)00957.
     

     >> Share

     
     
133. D'ALESSIO A, Pinato DJ
     Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
     Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.
     

     >> Share

     
     
134. DEBOSCH B
     Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
     Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.
     

     >> Share

     
     
135. CLIFFORD C, Ryan R, Houlihan D
     An interesting case of hepatomegaly.
     Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.
     

     >> Share

     
     
136. LO GH
     The beauty and sorrow of using PPI in patients with cirrhosis.
     Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.
     

     >> Share

     
     
137. MULLISH BH
     Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2022;163:528-529.
     

     >> Share

     
     
138. LE COSQUER G, Brunac AC, Peron JM
     An Unusual Case of Budd-Chiari Syndrome: Diagnosis and Treatment.
     Gastroenterology. 2022;163:e4-e5.
     

     >> Share

     
     July 2022
139. BENHAMMOU JN, Rich NE, Cholankeril G, Zhang P, et al
     DETECT: Development of Technologies for Early HCC Detection.
     Gastroenterology. 2022;163:21-27.
     

     >> Share

     
     
140. JAN J, Osho A, Murphy CC, Mazure CM, et al
     Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer.
     Gastroenterology. 2022;163:14-20.
     

     >> Share

     
     
141. TERRAULT NA, Williamson C
     Pregnancy-Associated Liver Diseases.
     Gastroenterology. 2022;163:97-117.
     

     >> Share

     
     
142. KARACHALIOU GS, Shi C, Abdelmalek MF
     Liver Mass: Thinking Out of the Box.
     Gastroenterology. 2022;163:e10-e12.
     

     >> Share

     
     June 2022
143. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
     Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
     Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.
     

     >> Share

     
     
144. BLAIR AB, Wang J, Davelaar J, Baker A, et al
     Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.
     Gastroenterology. 2022 Jun 16. pii: S0016-5085(22)00645.
     

     >> Share

     
     
145. YING X, Rosenblatt R, Fortune BE
     Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States from 2014 to 2020.
     Gastroenterology. 2022 Jun 14. pii: S0016-5085(22)00647.
     

     >> Share

     
     
146. DUURSMA SS, Verkade HJ, Bodewes FAJA
     Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
     Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.
     

     >> Share

     
     
147. BAUER KC, Littlejohn PT, Ayala V, Creus-Cuadros A, et al
     Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.
     Gastroenterology. 2022;162:1858-1875.
     

     >> Share

     
     
148. SULLIVAN S, Jirapinyo P, Kumbhari V
     Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
     Gastroenterology. 2022;162:2131-2132.
     

     >> Share

     
     May 2022
149. WANG J, Liu D, Chen S
     Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
     Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
     

     >> Share

     
     
150. NATSUI K, Maruyama M, Terai S
     Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?
     Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.
     

     >> Share

     
     
151. HU S, Molina L, Tao J, Liu S, et al
     NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma.
     Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
     

     >> Share

     
     
152. SINGH SP
     Proton pump inhibitor increasing the risk of infection and mortality in cirrhosis- need closer look!
     Gastroenterology. 2022 May 2. pii: S0016-5085(22)00458.
     

     >> Share

     
     
153. DONNELLY MC, Stableforth W, Krag A, Reuben A, et al
     The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary.
     Gastroenterology. 2022;162:1561-1567.
     

     >> Share

     
     
154. GOUDSMIT BFJ, Putter H, Van Hoek B
     The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
     Gastroenterology. 2022;162:1781-1782.
     

     >> Share

     
     
155. GAN W, Liao B, Li X
     A Rare Cause of Liver Fibrosis in Adulthood.
     Gastroenterology. 2022;162:e1-e3.
     

     >> Share

     
     April 2022
156. CACCIOLA I
     Effects of PPIs in cirrhotic patients: What do we really know?
     Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.
     

     >> Share

     
     
157. COPPS KD, Tao R
     A role for hepatic insulin signaling in alpha1-antitrypsin deficiency.
     Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00457.
     

     >> Share

     
     
158. MAHMUD N, Serper M, Taddei TH, Kaplan DE, et al
     The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.
     Gastroenterology. 2022 Apr 6. pii: S0016-5085(22)00352.
     

     >> Share

     
     
159. YANG Y, Ju C
     Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?
     Gastroenterology. 2022;162:1035-1037.
     

     >> Share

     
     
160. XU P, Xi Y, Wang P, Luka Z, et al
     Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure.
     Gastroenterology. 2022;162:1226-1241.
     

     >> Share

     
     
161. QIAN T, Fujiwara N, Koneru B, Ono A, et al
     Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
     Gastroenterology. 2022;162:1210-1225.
     

     >> Share

     
     March 2022
162. RUDNICK DA, Huang J, Hidvegi T, Chu AS, et al
     Regulation of PGC1alpha downstream of the insulin signaling pathway plays a role in the hepatic proteotoxicity of mutant alpha1-antitrypsin deficiency variant Z.
     Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00261.
     

     >> Share

     
     
163. VELENOSI TJ, Ben-Yakov G, Podszun MC, Hercun J, et al
     Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease.
     Gastroenterology. 2022 Mar 10. pii: S0016-5085(22)00235.
     

     >> Share

     
     
164. ALTAYAR O, Shah R, Chang CY, Falck-Ytter Y, et al
     AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
     Gastroenterology. 2022;162:937-951.
     

     >> Share

     
     
165. SU GL, Altayar O, O'Shea R, Shah R, et al
     AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
     Gastroenterology. 2022;162:920-934.
     

     >> Share

     
     
166. MAYDEO A, Patil G
     How to Approach a Patient With Gastric Varices.
     Gastroenterology. 2022;162:689-695.
     

     >> Share

     
     February 2022
167. CHENG N, Ren Y, Zhou J, Zhang Y, et al
     Deep learning-based classification of hepatocellular nodular lesions on whole-slide histopathologic images.
     Gastroenterology. 2022 Feb 21. pii: S0016-5085(22)00155.
     

     >> Share

     
     
168. CARRIQUE L, Lynch J, Selzner N
     We thank Bekki et al and Bhagat et al for their comments on our article "Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse". Bekki et al pointed out a trend toward inferior graft su
     Gastroenterology. 2022 Feb 3. pii: S0016-5085(22)00103.
     

     >> Share

     
     
169. STRAZZABOSCO M, Cabibbo G, Colombo M
     Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future.
     Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00090.
     

     >> Share

     
     
170. KANNEGANTI M, Singal AG
     INCIDENCE OF HEPATOCELLULAR CARCINOMA IN NONALCOHOLIC FATTY LIVER DISEASE.
     Gastroenterology. 2022 Feb 1. pii: S0016-5085(22)00092.
     

     >> Share

     
     
171. LEE SK, Wong JC, Ng JJ
     An Uncommon Cause of Hematemesis in a Patient With End-stage Renal Disease.
     Gastroenterology. 2022;162:404-405.
     

     >> Share

     
     
172. TAI Y, Wang Z, Wu H
     An Unusual Cause of Isolated Gastric Varices.
     Gastroenterology. 2022;162:e4-e6.
     

     >> Share

     
     
173. QU C, Wang HY, Xiu DR
     A Rare Liver Tumor Nodule.
     Gastroenterology. 2022;162:e1-e3.
     

     >> Share

     
     January 2022
174. WILLIAMS R, White PM, Balzora S
     "A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology".
     Gastroenterology. 2022 Jan 21. pii: S0016-5085(22)00035.
     

     >> Share

     
     
175. WILSON SR, Duncan AW
     Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution.
     Gastroenterology. 2022;162:46-48.
     

     >> Share

     
     December 2021
176. YANG AH, Gandhi S, Urrunaga NH
     Liver Tumor post Liver Transplantation for Hepatitis C Cirrhosis: An Unusual Cause.
     Gastroenterology. 2021 Dec 26. pii: S0016-5085(21)04161.
     

     >> Share

     
     
177. FORNER A, Colombo M
     The maze of systemic therapy for hepatocellular carcinoma: did we find the compass?
     Gastroenterology. 2021 Dec 23. pii: S0016-5085(21)04121.
     

     >> Share

     
     
178. KEFALAKES H
     DISPARITIES IN CIRRHOSIS MANAGEMENT OF BLACK PATIENTS: DO WE KNOW WHAT TO ADDRESS?
     Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03811.
     

     >> Share

     
     
179. GERMAN MN, Brown R, Lucey MR
     Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease.
     Gastroenterology. 2021;161:1795-1797.
     

     >> Share

     
     
180. POLLO-FLORES P, Trebicka J
     Statins After Variceal Bleeding Are Beneficial, but Still an Unexplained Mystery?
     Gastroenterology. 2021;161:2067-2068.
     

     >> Share

     
     
181. BARRITT AS 4TH, Moon AM
     Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease-Effective Intervention for a Select Few.
     Gastroenterology. 2021;161:2063-2064.
     

     >> Share

     
     
182. RAMAI D, Facciorusso A
     Liver Cancer Reduction After Bariatric Surgery: Time to Expand Its Indication?
     Gastroenterology. 2021;161:2063.
     

     >> Share

     
     
183. KIM WR, Mannalithara A, Heimbach JK, Kamath PS, et al
     MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
     Gastroenterology. 2021;161:1887-1895.
     

     >> Share

     
     
184. SACK JS, Patel RS, Ahmad J
     Nausea and Vomiting 8 Months After Liver Transplantation.
     Gastroenterology. 2021;161:e12-e14.
     

     >> Share

     
     November 2021
185. LOOMBA R, Ratziu V, Harrison SA
     Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
     Gastroenterology. 2021 Nov 22. pii: S0016-5085(21)03795.
     

     >> Share

     
     
186. BHAGAT N, Rathi S, Singh V
     Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse.
     Gastroenterology. 2021 Nov 5. pii: S0016-5085(21)03724.
     

     >> Share

     
     
187. KANWAL F, Shubrook JH, Adams LA, Pfotenhauer K, et al
     Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2021;161:1657-1669.
     

     >> Share

     
     
188. WANG X, Cheng Z
     Nodules on the Lower Legs With Ankle Joint Pain.
     Gastroenterology. 2021;161:1390-1392.
     

     >> Share

     
     
189. VARGAS JF, Arab JP
     Pulsatile Epigastric Mass and Liver Masses in a 38-Year-Old Patient With Splenomegaly Since Childhood.
     Gastroenterology. 2021;161:e14-e16.
     

     >> Share

     
     October 2021
190. LEE TH, Roper J, King L
     MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS.
     Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
     

     >> Share

     
     
191. LIU N, Chang CW, Steer CJ, Wang XW, et al
     MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.
     Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03652.
     

     >> Share

     
     
192. PEERY AF, Crockett SD, Murphy CC, Jensen ET, et al
     Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
     Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03655.
     

     >> Share

     
     
193. LOUISSAINT J, Gibbs JT, Lok AS, Tapper EB, et al
     Strategies to Improve Video Visit Use in Persons With Liver Disease.
     Gastroenterology. 2021;161:1080-1084.
     

     >> Share

     
     September 2021
194. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
     AGA Technical Review on Coagulation in Cirrhosis.
     Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.
     

     >> Share

     
     
195. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
     AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
     Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.
     

     >> Share

     
     
196. DREYER SB, Upstill-Goddard R, Legrini A, Biankin AV, et al
     Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence.
     Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03522.
     

     >> Share

     
     
197. BEKKI Y, Fenig Y
     Evaluation of Early Liver Transplantation for Alcohol-Related Cirrhosis.
     Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03491.
     

     >> Share

     
     
198. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
     Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.
     Gastroenterology. 2021 Sep 3. pii: S0016-5085(21)03335.
     

     >> Share

     
     
199. GUO L, Yi X, Chen L, Zhang T, et al
     Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma.
     Gastroenterology. 2021 Sep 2. pii: S0016-5085(21)03471.
     

     >> Share

     
     
200. KANWAL F, Shubrook JH, Younossi Z, Natarajan Y, et al
     Preparing for the NASH Epidemic: A Call to Action.
     Gastroenterology. 2021;161:1030-1042.
     

     >> Share

     
     
201. HABER PK, Puigvehi M, Castet F, Lourdusamy V, et al
     Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
     Gastroenterology. 2021;161:879-898.
     

     >> Share

     
     
202. DE BUCOURT M
     A Visual Engram Worth Remembering.
     Gastroenterology. 2021;161:809-810.
     

     >> Share

     
     
203. FUCHS A, Samovski D, Smith GI, Cifarelli V, et al
     Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2021;161:968-981.
     

     >> Share

     
     August 2021
204. BALZORA S, May FP, Ogedegbe G
     COVID-19 and Social Determinants of Health in Gastroenterology and Hepatology.
     Gastroenterology. 2021 Aug 26. pii: S0016-5085(21)03438.
     

     >> Share

     
     
205. SU F
     COVID-19 and cirrhosis: a combination we must strive to prevent.
     Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.
     

     >> Share

     
     
206. AZZIMATO V, Chen P, Barreby E, Morgantini C, et al
     Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity.
     Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03410.
     

     >> Share

     
     
207. OLYNYK JK, Ramm GA
     RISK OF LIVER CANCER IN HFE-HEMOCHROMATOSIS.
     Gastroenterology. 2021 Aug 19. pii: S0016-5085(21)03405.
     

     >> Share

     
     
208. TAI CS, Ni YH, Lee PI
     An Unusual Case with a Huge Hepatic Cystic Mass.
     Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03357.
     

     >> Share

     
     
209. CARRIQUE L, Quance J, Tan A, Abbey S, et al
     Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
     Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
     

     >> Share

     
     
210. GOUGH NR, Xiang X, Mishra L
     TGF-beta Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer.
     Gastroenterology. 2021;161:434-452.
     

     >> Share

     
     July 2021
211. MEHTA N, Frenette C, Tabrizian P, Hoteit M, et al
     Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
     Gastroenterology. 2021 Jul 28. pii: S0016-5085(21)03284.
     

     >> Share

     
     
212. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
     TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
     Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
     

     >> Share

     
     
213. GE J, Pletcher MJ, Lai JC
     Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
     Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
     

     >> Share

     
     
214. YE P, Miao H, Chen Y
     An unusual case of symptomatic portal hypertension.
     Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.
     

     >> Share

     
     
215. MAAN R, Darwish Murad S, van der Meer AJ
     Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
     Gastroenterology. 2021;161:371-372.
     

     >> Share

     
     
216. LI L, Liu C, Qi X
     Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
     Gastroenterology. 2021;161:370-371.
     

     >> Share

     
     
217. PARIKH ND, Chung GS, Mellinger J, Blanchette JG, et al
     Alcohol Policies and Alcohol-related Liver Disease Mortality.
     Gastroenterology. 2021;161:350-352.
     

     >> Share

     
     
218. RUSTGI VK, Li Y, Gupta K, Minacapelli CD, et al
     Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.
     Gastroenterology. 2021;161:171-184.
     

     >> Share

     
     
219. SURAPANENI PK, Mills K, Renelus BD
     A Rare Complication of Sickle Cell Anemia.
     Gastroenterology. 2021;161:45-46.
     

     >> Share

     
     June 2021
220. CHIANG HC, Chien SC, Lin YJ
     Pleural effusion with gastric ulcer.
     Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03176.
     

     >> Share

     
     
221. TSOI AH, Garg M, Tsoi EH
     Peptic ulcer disease: an unusual presentation of a common problem.
     Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03174.
     

     >> Share

     
     
222. VALENTI L, Mondelli M, Colombo M
     Liver field during immunotherapy of hepatocellular carcinoma: some like it hot.
     Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03165.
     

     >> Share

     
     
223. LI H, Liu H
     Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
     Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.
     

     >> Share

     
     
224. MEDICI V
     Expanding the Diagnostic Toolkit of Wilson Disease with ATP7B Peptides.
     Gastroenterology. 2021;160:2249-2251.
     

     >> Share

     
     
225. SU P, Hong J, Li T
     An Uncommon Lesion of the Liver.
     Gastroenterology. 2021;160:2258-2260.
     

     >> Share

     
     
226. COLLINS CJ, Yi F, Dayuha R, Duong P, et al
     Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.
     Gastroenterology. 2021;160:2367-2382.
     

     >> Share

     
     May 2021
227. EDWARDS LA, Goldenberg SD, Shawcross DL
     Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
     Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.
     

     >> Share

     
     
228. GARCIA-TSAO G, Abraldes JG
     Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
     Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.
     

     >> Share

     
     
229. PERRY IE, Azam MU, Yap JE
     Carcinoma Camouflage.
     Gastroenterology. 2021;160:1940-1942.
     

     >> Share

     
     
230. SHEN C, Zong Z, Xu N
     "Malignant" Liver Cysts Cause Liver Failure and Recurrence.
     Gastroenterology. 2021;160:e7-e9.
     

     >> Share

     
     
231. NAYAK LJ, Sondhi AR, Westerhoff M
     History!
     Gastroenterology. 2021;160:e5-e6.
     

     >> Share

     
     
232. HA NB, Wang CW, El-Nachef N
     An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.
     Gastroenterology. 2021;160:e1-e4.
     

     >> Share

     
     April 2021
233. PACK M
     Model Organisms Help Define the ABCs of Neonatal Cholestasis.
     Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00636.
     

     >> Share

     
     
234. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
     Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
     Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
     

     >> Share

     
     
235. SHEEHAN JL, Brandler J, Rice MD
     A Case of Recurrent Hepatic Abscesses.
     Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
     

     >> Share

     
     
236. PONZIANI FR, Nesci A, Del Zompo F, Santopaolo F, et al
     Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection.
     Gastroenterology. 2021;160:1891-1893.
     

     >> Share

     
     
237. KHAN MU, Mushtaq K, Alkaabi SR
     Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease.
     Gastroenterology. 2021;160:1894-1895.
     

     >> Share

     
     
238. VERMA N, Duseja A, Singh V
     Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease.
     Gastroenterology. 2021;160:1893-1894.
     

     >> Share

     
     
239. LUUKKONEN PK, Salomaa V, Aberg F
     The Pi *MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.
     Gastroenterology. 2021;160:1874-1875.
     

     >> Share

     
     
240. JAMIALAHMADI O, Mancina RM, Ciociola E, Tavaglione F, et al
     Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
     Gastroenterology. 2021;160:1634-1646.
     

     >> Share

     
     March 2021
241. ASSELTA R, Paraboschi EM, Gerussi A, Cordell HJ, et al
     X chromosome contribution to the genetic architecture of primary biliary cholangitis.
     Gastroenterology. 2021 Mar 3. pii: S0016-5085(21)00466.
     

     >> Share

     
     
242. CASADEI-GARDINI A, Cascinu S, Colombo M
     Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
     Gastroenterology. 2021;160:1423-1424.
     

     >> Share

     
     
243. GOLDBERG D, Ross-Driscoll K, Lynch R
     County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
     Gastroenterology. 2021;160:1140-1150.
     

     >> Share

     
     
244. KOBAYASHI H, Gieniec KA, Wright JA, Wang T, et al
     The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
     Gastroenterology. 2021;160:1224-1239.
     

     >> Share

     
     
245. PRZYBYSZEWSKI EM, Deshpande V, Uchida AM
     An Unsuspected Cause of Rectal Bleeding.
     Gastroenterology. 2021;160:e1-e2.
     

     >> Share

     
     February 2021
246. YOUNOSSI ZM, Corey KE, Lim JK
     AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
     Gastroenterology. 2021;160:912-918.
     

     >> Share

     
     
247. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
     High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
     Gastroenterology. 2021;160:831-846.
     

     >> Share

     
     
248. NASSANI N, Melitas C, Villa E
     An Unusual Cause of Watery Diarrhea.
     Gastroenterology. 2021;160:671-674.
     

     >> Share

     
     January 2021
249. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
     How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
     Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
     

     >> Share

     
     
250. ACHARYA C, Bajaj JS
     Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
     Gastroenterology. 2021;160:556-572.
     

     >> Share

     
     
251. NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
     Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
     Gastroenterology. 2021;160:193-205.
     

     >> Share

     
     December 2020
252. VAN DIJK M, Weehuizen TAF, Lowenberg M
     A rare cause of acute abdominal pain after endoscopic retrograde cholangiopancreaticography.
     Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35559.
     

     >> Share

     
     
253. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
     Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
     Gastroenterology. 2020;159:2232-2234.
     

     >> Share

     
     November 2020
254. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
     Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
     Gastroenterology. 2020;159:1985-1987.
     

     >> Share

     
     
255. XANTHAKOS SA, Lavine JE, Yates KP, Schwimmer JB, et al
     Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
     Gastroenterology. 2020;159:1731-1751.
     

     >> Share

     
     
256. LANG S, Demir M, Martin A, Jiang L, et al
     Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2020;159:1839-1852.
     

     >> Share

     
     October 2020
257. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
     Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
     Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
     

     >> Share

     
     
258. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
     AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
     Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
     

     >> Share

     
     
259. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
     Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
     Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
     

     >> Share

     
     
260. DE VRIES E, Bolier R, Goet J, Pares A, et al
     Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
     Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
     

     >> Share

     
     
261. ROMEO S
     MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
     Gastroenterology. 2020;159:1231-1232.
     

     >> Share

     
     
262. RAMLI MNB, Lim YS, Koe CT, Demircioglu D, et al
     Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
     Gastroenterology. 2020;159:1471-1486.
     

     >> Share

     
     September 2020
263. VILAR-GOMEZ E, Sookoian S, Pirola CJ, Liang T, et al
     ADH1B *2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
     Gastroenterology. 2020;159:929-943.
     

     >> Share

     
     
264. CHAI C, Cox B, Yaish D, Gross D, et al
     Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
     Gastroenterology. 2020;159:999-1014.
     

     >> Share

     
     
265. WANG Y, Pan Y, Zhou Z
     An Unusual Cause of Fever in a Man With a Liver Mass.
     Gastroenterology. 2020;159:842-844.
     

     >> Share

     
     August 2020
266. JANSSON-KNODELL CL, Walker MJ, Fischer M
     Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
     Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
     

     >> Share

     
     
267. NABI O, Lacombe K, Boursier J, Mathurin P, et al
     Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
     Gastroenterology. 2020;159:791-793.
     

     >> Share

     
     
268. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
     Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
     Gastroenterology. 2020;159:534-548.
     

     >> Share

     
     
269. GUPTA V, Gupta I, Park J, Bram Y, et al
     Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
     Gastroenterology. 2020;159:624-638.
     

     >> Share

     
     
270. NAUDIN CR, Maner-Smith K, Owens JA, Wynn GM, et al
     Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
     Gastroenterology. 2020;159:639-651.
     

     >> Share

     
     June 2020
271. RUETHER DF, Menz A, Manthey CF
     A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
     Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share